IBD--MUCOSA-SPECIFIC REGULATION OF IFN-GAMMA PRODUCTION
IBD--粘膜特异性的 IFN-γ 产生调节
基本信息
- 批准号:6288345
- 负责人:
- 金额:$ 30.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:CD2 molecule CD28 molecule JAK kinase T cell receptor T lymphocyte gene expression genetic promoter element human subject human tissue immunogenetics immunopathology immunoregulation inflammatory bowel diseases interferon gamma interleukin 2 intestinal mucosa introns leukocyte activation /transformation mucosal immunity oligonucleotides patient oriented research phosphorylation tissue /cell culture transfection tumor necrosis factor alpha
项目摘要
DESCRIPTION: (Adapted from the Applicant's Abstract): T-cell production of
IFN-gamma plays an essential role in disease initiation and severity of disease
in animal models and Crohn's disease. Mucosal T-cells are different from
peripheral T-cells in several ways. Mucosal T-cells are muted responders to
activation via the T-cell receptor and are CD2 pathway dominant. During the
previous award period the investigators used their ability to transfect primary
T-cells to show unique mucosa-specific mechanisms by which T-cells produced Th1
cytokines. They demonstrated a role for AP1 in CD2 transactivation of the IL-2
gene. They showed that enhanced IL-2 production by CD2/CD28 co-activated
peripheral T-cells occurs through mRNA stabilization and trans-activation in
peripheral T-cells, however, in mucosal T-cells this effect can be solely the
result of mRNA stabilization. This difference is due to the lack of activation
of the AP1 and CD28 response elements in the IL-2 promotor in mucosal cells.
They demonstrated several mucosal-specific mechanisms of IFN-gamma regulation
and identified a unique role for TNF-alpha in mucosal T-cell IFN-gamma
regulation. They defined the lamina propria mononuclear cell factor which can
prime T-cells to respond to TNF-alpha. Furthermore, they demonstrated different
cis elements in the IFN-gamma promotor that are used for transactivation of the
IFN-gamma gene and mucosal T-cells as compared to peripheral T-cells. Finally,
they demonstrated for the first time the enhancer function of the first
intronic region of the IFN-gamma gene that involves the JAK/STAT pathway in
mucosal T-cells but not in peripheral T-cells. Because of the vital importance
of IFN-gamma in disease related mucosal inflammation yet its critical role for
host defense, the knowledge of mucosa-specific targets, which would selectively
attenuate mucosal IFN-gamma production without eliminating, would be a
significant accomplishment. The overall objective of this continuation proposal
is to more precisely define the mucosal specific regulatory pathways that are
important for IFN-gamma regulation in T-cells and to use this knowledge to
design approaches to modify IFN-gamma production in a mucosa-specific manner.
This will be accomplished by the following specific aims: To identify through
fine promotor analysis positive and negative cis-regulatory regions within the
IFN-gamma promotor in which transcriptional regulation in lamina propria
mononuclear cells differ from that in peripheral blood lymphocytes focusing on
the previously identified regions of -204 to -108 (enhancer) and -528 to -204
base pair (repressor). To determine the mucosa-specific mechanisms of
regulating the first intronic region of the IFN-gamma gene. From the results of
Aim 1 and Aim 2 design molecular approaches including transfection of antisense
oligonucleotides and or dominant negative transacting factors to attenuate in
vitro IFN-gamma promotor expression in a mucosal-specific manner.
描述:(根据申请人的摘要改编):
IFN-gamma在疾病开始和疾病严重程度中起着至关重要的作用
在动物模型和克罗恩病。粘膜T细胞不同于
外围T细胞有几种方式。粘膜T细胞是反应者
通过T细胞受体的激活,是CD2途径的主导性。在
以前的奖项期调查人员使用其转染的能力
T细胞显示出独特的粘膜特异性机制,T细胞产生Th1
细胞因子。他们证明了AP1在IL-2的CD2反式激活中的作用
基因。他们表明,CD2/CD28共激活IL-2的产生增强
周围T细胞通过mRNA稳定和反式激活发生
但是,外围T细胞,在粘膜T细胞中,这种效应只能是
mRNA稳定的结果。这种差异是由于缺乏激活
粘膜细胞中IL-2启动子中的AP1和CD28响应元件的。
他们证明了IFN-gamma调节的几种粘膜特异性机制
并确定了TNF-Alpha在粘膜T细胞IFN-Gamma中的独特作用
规定。他们定义了固定层单核细胞因子
Prime T细胞应对TNF-Alpha。此外,他们证明了不同的
IFN-gamma启动子中用于反式激活的元素
与周围T细胞相比,IFN-GAMMA基因和粘膜T细胞。最后,
他们首次证明了第一个的增强功能
IFN-GAMMA基因的内含子区域,涉及jak/stat途径
粘膜T细胞,但不在外周T细胞中。因为至关重要
IFN-Gamma在疾病相关的粘膜炎症中的关键作用
宿主防御,粘膜特定目标的知识,这将有选择地
衰减粘膜IFN-gamma生产而不消除,将是
重大成就。该延续建议的总体目标
是更精确地定义粘膜特定的调节途径
对于T细胞中的IFN-Gamma调节很重要,并将这些知识用于
设计方法以粘膜特异性方式修饰IFN-gamma生产。
这将通过以下具体目的来完成:通过
精细的启动子分析阳性和负顺式调节区域
IFN-gamma启动子在层次中转录调节
单核细胞与关注的外周血淋巴细胞不同
以前确定的区域为-204至-108(增强器)和-528至-204
基对(阻遏物)。确定粘膜特异性机制
调节IFN-GAMMA基因的第一个内含子区域。从结果
AIM 1和AIM 2设计分子方法,包括反义转染
在
体外IFN-gamma启动子以粘膜特异性方式表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephan R. Targan其他文献
Serial 6-mercaptopurine (6-MP) metabolite measurements in combination with dose escalation unmasks an important biochemical explanation for "6-MP resistance"
- DOI:
10.1016/s0016-5085(00)85698-x - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Marla C. Dubinsky;Philip V. Hassard;Lori Y. Kam;Maria T. Abreu;Ernest G. Seidman;Stephan R. Targan;Eric A. Vasiliauskas - 通讯作者:
Eric A. Vasiliauskas
Thioguanine (6-TG): A therapeutic alternative in a subgroup of IBD patients failing 6-mercaptopurine (6-MP)
- DOI:
10.1016/s0016-5085(00)85701-7 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Marla C. Dubinsky;Philip V. Hassard;Maria T. Abreu;Lori Y. Kam;Ernest G. Seidman;Stephan R. Targan;Eric A. Vasiliauskas - 通讯作者:
Eric A. Vasiliauskas
Tu1740 – Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 Unifi Maintenance Study
- DOI:
10.1016/s0016-5085(19)39726-4 - 发表时间:
2019-05-01 - 期刊:
- 影响因子:
- 作者:
Gert A. Van Assche;Stephan R. Targan;Thomas Baker;Christopher D. O'Brien;Hongyan Zhang;Jewel Johanns;Philippe Szapary;Colleen W. Marano;Rupert W. Leong;David Rowbotham;Tadakazu Hisamatsu;Silvio Danese;Bruce E. Sands;Laurent Peyrin-Biroulet - 通讯作者:
Laurent Peyrin-Biroulet
Tu1764 - Tl1A Deficiency (But not Dr3-Deficiency) Protects from the Development of Colitis in the Chronic T Cell Transfer Mouse Model by Decreasing Th1 Cell Accumulation in the Intestinal Mucosa
- DOI:
10.1016/s0016-5085(18)33390-0 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Yosuke Shimodaira;Yoshitake Kanazawa;Jay P. Abraham;Kotaro Kumagai;Noam Jacob;Yuefang Ye;Justin Luu;Kathrin S. Michelsen;Stephan R. Targan;David Shih - 通讯作者:
David Shih
Tu1797 - Multi-Center Cohort Analysis Identified a Genetic Association in Complement Factor B with Perianal Crohn's Disease
- DOI:
10.1016/s0016-5085(18)33423-1 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Marcy Akhlaghpour;Talin Haritunians;Emebet Mengesha;Dalin Li;Zhenqiu Liu;Randall McNally;Carol Landers;Karen Zaghiyan;Phillip Fleshner;Gil Melmed;Stephan R. Targan;Mark S. Silverberg;Kathrin S. Michelsen;Dermot McGovern - 通讯作者:
Dermot McGovern
Stephan R. Targan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephan R. Targan', 18)}}的其他基金
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10077845 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10539302 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD
IBD 中 TL1A 驱动的潘氏细胞功能障碍的机制
- 批准号:
10311509 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
Molecular characterization of the role of RNASET2 in Severe Crohn's Disease
RNASET2 在严重克罗恩病中作用的分子表征
- 批准号:
10021036 - 财政年份:2019
- 资助金额:
$ 30.6万 - 项目类别:
Molecular characterization of the role of RNASET2 in Severe Crohn's Disease
RNASET2 在严重克罗恩病中作用的分子表征
- 批准号:
10226172 - 财政年份:2019
- 资助金额:
$ 30.6万 - 项目类别:
Role of TRIF-Dependent TLR Signaling in Intestinal Mucosa
TRIF 依赖性 TLR 信号转导在肠粘膜中的作用
- 批准号:
10225616 - 财政年份:2012
- 资助金额:
$ 30.6万 - 项目类别:
IBD: Mucosa Specific Regulation of IFN-gamma Production
IBD:粘膜对 IFN-γ 产生的特异性调节
- 批准号:
7921223 - 财政年份:2009
- 资助金额:
$ 30.6万 - 项目类别:
INFLAMMATORY BOWEL DISEASE CENTER: CLINICAL DATA REPOSITORY - TISSUE PROCUREMENT
炎症性肠病中心:临床数据存储库 - 组织采购
- 批准号:
8174459 - 财政年份:2009
- 资助金额:
$ 30.6万 - 项目类别:
INFLAMMATORY BOWEL DISEASE CENTER: CLINICAL DATA REPOSITORY - TISSUE PROCUREMENT
炎症性肠病中心:临床数据存储库 - 组织采购
- 批准号:
7952200 - 财政年份:2008
- 资助金额:
$ 30.6万 - 项目类别:
CORE--TISSUE PROCUREMENT & DATA ANALYSIS & SERUM ANALYSIS
核心——纸巾采购
- 批准号:
7487329 - 财政年份:2007
- 资助金额:
$ 30.6万 - 项目类别:
相似海外基金
IBD--MUCOSA-SPECIFIC REGULATION OF IFN-GAMMA PRODUCTION
IBD--IFN-γ产生的粘膜特异性调节
- 批准号:
6687840 - 财政年份:2001
- 资助金额:
$ 30.6万 - 项目类别:
IBD--MUCOSA-SPECIFIC REGULATION OF IFN-GAMMA PRODUCTION
IBD--粘膜特异性的 IFN-γ 产生调节
- 批准号:
6626937 - 财政年份:2001
- 资助金额:
$ 30.6万 - 项目类别:
IBD--MUCOSA-SPECIFIC REGULATION OF IFN-GAMMA PRODUCTION
IBD--IFN-γ产生的粘膜特异性调节
- 批准号:
6829097 - 财政年份:2001
- 资助金额:
$ 30.6万 - 项目类别:
IBD--MUCOSA-SPECIFIC REGULATION OF IFN-GAMMA PRODUCTION
IBD--IFN-γ产生的粘膜特异性调节
- 批准号:
6489654 - 财政年份:2001
- 资助金额:
$ 30.6万 - 项目类别: